08/29/2026
Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report | PharmExec
President Donald Trump's administration is preparing to announce a new round of drug-pricing agreements with midsize biotech companies as soon as Aug. 31, 2026, according to sources familiar with the matter.
The Trump administration is expected to announce a new round of voluntary MFN drug-pricing agreements with midsize biotech companies as soon as August 31.